Tanaka Yuichiro, Takemae Toshiki, Kobayashi Shigeaki, Sakai Keiichi, Miyahara Takahiro, Ishizaka Shigetoshi, Kodama Kunihiko, Kobayashi Tatsuya, Ichikawa Yozo, Tsutsumi Keiji, Hongo Kazuhiro
Department of Neurosurgery, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto 390-8621, Japan.
No Shinkei Geka. 2007 Sep;35(9):887-93.
In order to improve QOL in patients with craniopharyngioma, retrospective analysis was performed to discover factors for influencing functional outcome and the best treatment strategy. 56 patients were treated between 1978 and 2005. They were initially treated with surgery and surgical cure was obtained in 29 patients (Group A). Subtotal tumor resection with prophylactic radiation was performed in 8 patients (Group D). Tumor recurrence was noted in 19 patients and stereotactic radiation or 2nd operation was performed in 11 patients (Group B). 2nd operation and fractionated radiation were undertaken in 8 patients (Group C). Endocrine, vision and recognition were scored from 2 to 0, respectively; 2 indicates normal, 1 partially disturbed, 0 fully disturbed. The mean score before treatment was 4.7 and the final score was 3.9. Factors leading to poor outcome included extrasellar origin, solid tumor, bad score before treatment, 2nd surgery for recurrence. The change of scores after the treatment was -0.1 in group A, -0.7 in Group B, -0.9 in Group C and 0.3 in Group D. Maximum tumor removal should be attempted with functional preservation. Subtotal removal with prophylactic radiation is recommended if the patient has normal hypothalamic function.
为改善颅咽管瘤患者的生活质量,进行回顾性分析以发现影响功能预后的因素及最佳治疗策略。1978年至2005年间对56例患者进行了治疗。他们最初接受手术治疗,29例患者获得手术治愈(A组)。8例患者行肿瘤次全切除并预防性放疗(D组)。19例患者出现肿瘤复发,11例患者接受立体定向放疗或二次手术(B组)。8例患者接受二次手术和分次放疗(C组)。内分泌、视力和认知功能评分分别从2至0分;2分表示正常,1分表示部分受干扰,0分表示完全受干扰。治疗前平均评分为4.7分,最终评分为3.9分。导致预后不良的因素包括鞍外起源、实体瘤、治疗前评分差、复发后二次手术。治疗后A组评分变化为-0.1分,B组为-0.7分,C组为-0.9分,D组为0.3分。应尝试在保留功能的前提下最大程度切除肿瘤。如果患者下丘脑功能正常,建议行次全切除并预防性放疗。